Skip to main content
. 2022 Mar 31;17:25. doi: 10.1186/s13011-022-00452-8

Table 3.

Unadjusted odds ratios and 99% confidence intervals for odds of reporting using a kit vs. not reporting using a kit

Characteristics Kit Used (Replacement—Used) (N = 90,011) Kit Not Useda (1st Kit or Replacement-Other) (N = 150,595) Total (N = 240,606) Bivariate Analysis
UOR (99% CI) p-value
n (%) n (%) n (%*)
Year
 2017 15,523 (24.5%) 47,824 (75.5%) 63,347 (26.3%) 1.00 -
 2018 21,309 (35.1%) 39,370 (64.9%) 60,679 (25.2%) 1.48 (1.42—1.54)  < 0.001
 2019 21,009 (39.9%) 31,691 (60.1%) 52,700 (21.9%) 1.83 (1.75—1.90)  < 0.001
 2020 32,170 (50.4%) 31,710 (49.6%) 63,880 (26.5%) 3.04 (2.92—3.16)  < 0.001
Health Region
 Fraser 28,392 (39.3%) 43,827 (60.7%) 72,219 (30.0%) 1.00 -
 Interior 23,273 (40.2%) 34,664 (59.8%) 57,937 (24.1%) 1.11 (1.08 – 1.15)  < 0.001
 Island 20,806 (36.8%) 35,657 (63.2%) 56,463 (23.5%) 0.96 (0.93 – 0.99)  0.001
 Northern 6,129 (33.1%) 12,398 (66.9%) 18,527 (7.7%) 0.72 (0.69 – 0.76)  < 0.001
 Vancouver Coastal 11,385 (32.5%) 23,601 (67.5%) 34,986 (14.5%) 0.70 (0.67 – 0.73)  < 0.001
 Unknown 26 (5.5%) 448 (94.5%) 474 (0.2%) - -
Risk of Overdose
 Not at Risk 6,949 (13.5%) 44,692 (86.5%) 51,641 (21.5%) 1.00 -
 At Risk 75,667 (50.2%) 74,967 (49.8%) 150,634 (62.6%) 7.02 (6.76—7.29)  < 0.001
 Unknown 7,395 (19.3%) 30,936 (80.7%) 38,331 (15.9%) - -
Gender
 Male 49,170 (42.2%) 67,253 (57.8%) 116,423 (48.4%) 1.00 -
 Female 36,712 (36.3%) 64,525 (63.7%) 101,237 (42.1%) 0.79 (0.77—0.81)  < 0.001
 Trans or Gender Expansive 1,625 (30.8%) 3,647 (69.2%) 5,272 (2.2%) 0.48 (0.43—0.53)  < 0.001
 Unknown 2,504 (14.2%) 15,170 (85.8%) 17,674 (7.3%) - -
Age Group
 Under 19 2,772 (25.6%) 8,071 (74.4%) 10,843 (4.5%) 1.00 -
 19—30 29,710 (38.9%) 46,599 (61.1%) 76,309 (31.7%) 1.82 (1.71—1.93)  < 0.001
 31—60 52,545 (41.7%) 73,325 (58.3%) 125,870 (52.3%) 2.04 (1.92—2.17)  < 0.001
 Over 60 1,887 (26.0%) 5,380 (74.0%) 7267 (3.0%) 0.99 (0.90—1.09) 0.834
 Unknown 3,097 (15.2%) 17,220 (84.8%) 20,317 (8.4%) - -

Abbreviations: UOR unadjusted odds ratio, CI confidence interval

*Column percentages

aTake-home naloxone kit was recipient’s first kit or replacement due to a previous kit being lost, stolen, confiscated or expired